Phase I study of VSV-GP (BI 1831169) as monotherapy or combined with ezabenlimab in advanced and refractory solid tumors

Author:

Porosnicu, Mercedes; Quinson, Anne-Marie; Crossley, Kate; Luecke, Stephan; Lauer, Ulrich M.

Tübinger Autor(en):

Published in:

Future Oncology (2022), Bd. 18, H. 24, S. 2627-2638

Verlagsangabe:

Future Medicine Ltd

Language:

English

Full text:

ISSN:

1479-6694

DDC Classifikation:

610 - Medicine and health

Dokumentart:

Article

This item appears in the following Collection(s)